Innovations
SAM MEDICAL = A History Of Innovation
2011The valve version of the SAM Chest Seal was released. When its cap is removed, the one-way valve provides for low-resistance flow of air out of the chest cavity while preventing ingress. The valve is designed to prevent blockage internally from blood clots and soft tissue, and externally from items such as body armor, clothing, and blankets. With the cap in place, the dressing is occlusive.
2010
The SAM Chest Seal was launched in December at the Special Operations Medical Association (SOMA) 2010 Conference in Tampa, Fla. The SAM Chest Seal is a new occlusive dressing for treating open chest wounds. Features include strong adhesion in varied climates and skin conditions, and is optimized for use in no light conditions with a night vision device.
In October, we moved to our new 18,000 ft. facility in Wilsonville, OR, combining our manufacturing plant, R&D lab, and corporate offices.
In August, SAM Medical Products was named to the Inc. 5000 list of the Fastest Growing Private Companies in America for the fourth year in a row.
2009
Our innovative SAM Sling pelvic stabilizing belt has been further enhanced and renamed the SAM Pelvic Sling II. This new and improved version has been simplified to make it even easier to use. By converting to a one piece design, our sling can now be applied in only three steps. And it is reusable.
CELOX Trauma Gauze is introduced, providing medics with a dual-purpose gauze used to control traumatic bleeding and to cool and protect first- and second-degree burns. CELOX Trauma Gauze is composed entirely of CELOX's chitosan chemistry. When reacting with blood, the material controls bleeding within three minutes. When saturated with water or saline solution, the material becomes a gel-like material, to cool and protect the burn.
CELOX-D named as a Top Pick at the 2008 EMS EXPO. Top Picks recognize innovations in products and services for the pre-hospital market.
In August, SAM Medical Products is named to the Inc. 5000 list of the Fastest Growing Private Companies in America for the third year in a row.
2008
CELOX GAUZE is launched at the 2008 SOMA show in Orlando, FL. CELOX GAUZE is the newest CELOX delivery system and combines the groundbreaking CELOX agent with a fabric dressing. The dressing allows for easy and precise placement of the wound treatment.
SAM Medical Products is awarded a $1.2 million contract from the US Marine Corp for further development of new delivery systems for the CELOX™ wound treatment and for the development of higher performance CELOX chemistries to better treat life-threatening bleeding associated with battlefield trauma.
The latest addition to the CELOX line, new CELOX-D is one of the most innovative products to hit the market in years. CELOX-D uses the same chitosan based agent as traditional CELOX but its delivery system is what makes it unique and highly effective. The agent is contained in a soluble bag that is placed in the wound and begins to break down after making contact with blood. As the bag breaks down the agent is released into the wound. This delivery system allows CELOX-D to overcome the challenges typically associated with granular agents and makes it extremely effective.
In September, SAM Medical Products is named to the Inc. 5000 list of the Fastest Growing Private Companies in America for the second year in a row.
2007
CELOX-A was introduced when the needs of EMS providers, physicians, and medical providers is recognized for an applicator delivery system. The applicator and plunger system now makes it possible for the hemostatic agent to reach deep into the site of traumatic wounds, getting straight to the source of the bleeding.
SAM Medical Products is named to the Inc. 5000 list of the Fastest Growing Private Companies in America.
CELOX-A named as a Top Pick at the 2007 EMS EXPO. Top Picks recognize innovations in products and services for the pre-hospital market.
2006
CELOX™, a new high-performance hemostatic material is cleared by the FDA. CELOX™ is a proprietary marine biopolymer designed to control high-volume arterial bleeding. It is suitable for many applications, from deep arterial bleeds to superficial wounds, and generates no heat, works in hypothermic conditions and on Heparinized blood.
In late 2006, medical conference papers at SOMA and IEME were presented by LCDR Kozen of the US Navy. His presentations discussed the findings of a comparative study between CELOX, Hemcon, and QuikClot. Results showed that CELOX was at least as effective as Hemcon and QuikClot in controlling hemorrhage.
Drs. Polliack and Scheinberg publish findings from their National Institutes of Health study in Wilderness and Environmental Medicine journal. The study reveals that the BursaMed® adhesive bandage is effective in significantly reducing the coefficient of friction on able-bodied subjects. In addition, a laboratory study demonstrated the lowest coefficient of friction compared with commonly used products for skin protection. That same year, the Blistoban/Bursamed patent was granted.
Similar to the Blist-O-ban® bandage, the BursaMed® adhesive bandage was launched for applications in the podiatry, sports medicine and orthopedic markets.
2005
Our Soft Shell Splint receives Honorable Mention for The International Design Magazine 2005 Annual Design Review.
Our Blist-O-Ban adhesive line of bandages receives Honorable Mention for The International Design Magazine 2005 Annual Design Review.
The SAM Splint is featured in the exhibit SAFE: Design Takes on Risk at the Museum of Modern Art opening in Fall 2005.
Temple University School of Podiatry performed a study involving 100 subjects who walked 20 miles in warm rainy conditions. These walkers developed 5 times more blisters in areas not protected by the BursaMed™. The study was presented at the American Professional Wound Care Association Annual Meeting. Philadelphia, PA.
The Blist-O-Ban® adhesive bandages, incorporating the BursaTek® gliding dome, were launched with three sizes for foot and ankle applications. Runners and outdoor enthusiasts worldwide have since used the ultra-low profile bandage as part of their standard of care for blisters and abrasions.
2003
Drs Scheinberg and Polliack design, commercialize and patent the Soft Shell® Splint for forearm injuries. The Soft Shell® splint incorporates a dual-thickness aluminum core where one end is more rigid than the other, allowing for the wrist area to immobilized with the appropriate range or motion, as needed. An open cell foam and terry cloth cover provides for exceptional comfort. Three splint lengths and 2 widths allow for an array of splinting options.
After SAM® Pelvic Sling was launched, with its patented auto-stop buckle, containing two precision springs, ideal for reducing and stabilizing open-book pelvic fractures to the same compression force each and every time. The device also incorporates a tapered anterior belt with posterior low-friction surface that includes printed instructions for use.
2002
After a 3-year Department of Navy research grant, Legacy researchers Drs. Michael Bottlang and James Krieg, approach SAM Medical with their prototype autostop buckle and pelvic sling. The pelvic sling allows for consistent controlled circumferential compression, avoiding provider variability. The autostop buckle was biomechanically evaluated in cadaver and clinical research. Three peer-reviewed studies were published in orthopedic journals 2002 as a result of the study.
2001
First patent for the BursaTek® issued, describing the "gliding principle™" and the notion of an artificial bursa in reducing skin friction for blister prevention and treatment.
1999
Scheinberg serendipitously discovers the benefits of a two-layer bag in reducing pain and blister development in his shoe.
Trauma specialists at Legacy Research Center, Legacy Health System, Portland Oregon, , begin researching the ideal means to reduce and stabilize life-threatening pelvic ring fractures.
SAM Medical recognizes the need for all-weather, reusable notebook/checklist suitable for use in the most extreme conditions. The On-Scene Guide is brought to the marketplace.
1985
SAM® Splint exhibited at the World Fair in Vancouver, B.C. and launches product on the market. SAM Medical is incorporated and begins business as The Seaberg Co., Inc.
1984
First production of the SAM® Splint.
1976
First patent issued for universal splint that employs structural curves to create splinting rigidity
1975
Scheinberg unveils his invention, now called the SAM® Splint, as a technical exhibit at a meeting of the American Academy of Orthopedic Surgeons. The SAM Splint aluminum core, laminated with closed cell foam on both sides, can be shaped into a variety of structural curves. Once curved, the aluminum core becomes amazingly rigid. And it's reusable-the aluminum can be folded and unfolded numerous times, allowing the splint material to be reused as many times as desired. It's a technology that perfectly embodies SAM Medical Products' guiding principle: if you're going to make a product, find one that meets an important need and hone the technology until it sets a new standard of care.
1971
Orthopedic surgeon Sam Scheinberg recognizes the strength of curves and realizes how they can be harnessed for a reusable splint, far superior to existing products
ISO 13485:2003 Certified
Cage Code: 66215
